
The episode reviews recent updates in pancreatic cancer treatments, lipid management guidelines, and the use of GLP-1 agonists.
Join us as we review recent articles and news featured in The DIGEST, including updated lipid guidelines, GLP1 agonists holds and procedures, the newest drug in pancreatic cancer, and discontinuing thyroid supplementation. Fill your brain hole with a delicious stack of hotcakes! Featuring Drs. Nora Taranto ( @norataranto ), Laura Glick ( @lauraglick ) and Matt Watto (@doctorwatto) . Claim free CME for this episode at curbsiders.vcuhealth.org ! Episodes | Subscribe | Spotify | Swag! | Mailing List | Contact | CME! Credits Written and Hosted by: Nora Taranto MD MSCE, Laura Glick MD, Matthew Watto MD, FACP Cover Art: Nora Taranto MD MSCE Reviewers: Emi Okamoto MD Technical Production: Pod Paste Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Show Segments Intro and pun Lipid Management Guidelines Overview Emerging Treatments in Oncology Press Release on a new KRAS Inhibitor for Pancreatic Cancer Perioperative Considerations for GLP-1 Use Deprescribing Levothyroxine in Older Adults Sponsor: Panacea Financial If you're about to make the leap into residency and feeling the financial pressure of that transition, visit PanaceaFinancial.com/curbsiders today. Sponsor: UpToDate…
Hosts: Nora Taranto, Laura Glick, Matt Watto
Panacea Financial, UpToDate
Organizations: The DIGEST
Products: GLP1 agonists, KRAS Inhibitor, Levothyroxine
Explore listener stats, chart rankings, contacts and more on the The Curbsiders Internal Medicine Podcast podcast page.